Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | metacaspase, putative | 0.0373 | 0.1935 | 0.1935 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0413 | 0.2326 | 0.2326 |
Echinococcus granulosus | cathepsin b | 0.0181 | 0.0067 | 0.0067 |
Echinococcus multilocularis | caspase 8 | 0.0373 | 0.1935 | 0.1935 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.12 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0413 | 0.2326 | 0.2326 |
Plasmodium falciparum | metacaspase 1 | 0.0373 | 0.1935 | 0.1935 |
Echinococcus multilocularis | cathepsin b | 0.0181 | 0.0067 | 0.0067 |
Echinococcus granulosus | caspase | 0.0734 | 0.5458 | 0.5458 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.0181 | 0.0067 | 0.0067 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.12 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0373 | 0.1935 | 0.1935 |
Plasmodium vivax | metacaspase 1, putative | 0.0373 | 0.1935 | 0.1935 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0373 | 0.1935 | 0.1935 |
Loa Loa (eye worm) | hypothetical protein | 0.0181 | 0.0067 | 0.0067 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0734 | 0.5458 | 0.5458 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.12 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Plasmodium falciparum | metacaspase-like protein | 0.0373 | 0.1935 | 0.1935 |
Trypanosoma brucei | metacaspase MCA3 | 0.0373 | 0.1935 | 0.1935 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0413 | 0.2326 | 0.2326 |
Trypanosoma brucei | Metacaspase-4 | 0.0373 | 0.1935 | 0.1935 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.12 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Trypanosoma brucei | metacaspase 5, putative | 0.0373 | 0.1935 | 0.1935 |
Trypanosoma brucei | metacaspase | 0.0373 | 0.1935 | 0.1935 |
Leishmania major | proteasome beta 5 subunit, putative | 0.12 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.12 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.12 | 1 | 0.5 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.12 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0785 | 0.5955 | 0.5955 |
Echinococcus granulosus | caspase 3 | 0.0362 | 0.1829 | 0.1829 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0373 | 0.1935 | 0.1935 |
Echinococcus multilocularis | caspase 3 | 0.0362 | 0.1829 | 0.1829 |
Trypanosoma cruzi | metacaspase, putative | 0.0373 | 0.1935 | 0.1935 |
Onchocerca volvulus | 0.0413 | 0.2326 | 0.3905 | |
Plasmodium vivax | hypothetical protein, conserved | 0.0373 | 0.1935 | 0.1935 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0181 | 0.0067 | 0.0067 |
Echinococcus granulosus | caspase 2 | 0.0785 | 0.5955 | 0.5955 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0181 | 0.0067 | 0.0067 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.12 | 1 | 1 |
Brugia malayi | Cell death protein 3 precursor | 0.0785 | 0.5955 | 0.5955 |
Trypanosoma cruzi | metacaspase, putative | 0.0373 | 0.1935 | 0.1935 |
Echinococcus granulosus | cathepsin b | 0.0181 | 0.0067 | 0.0067 |
Loa Loa (eye worm) | hypothetical protein | 0.0413 | 0.2326 | 0.2326 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0734 | 0.5458 | 0.5458 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0373 | 0.1935 | 0.1935 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.12 | 1 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.0373 | 0.1935 | 0.1935 |
Echinococcus granulosus | caspase 8 | 0.0373 | 0.1935 | 0.1935 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0734 | 0.5458 | 0.5458 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0785 | 0.5955 | 0.5955 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0181 | 0.0067 | 0.0067 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0181 | 0.0067 | 0.0067 |
Trypanosoma brucei | metacaspase MCA2 | 0.0373 | 0.1935 | 0.1935 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0373 | 0.1935 | 0.1935 |
Echinococcus multilocularis | caspase 2 | 0.0785 | 0.5955 | 0.5955 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.12 | 1 | 1 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.0734 | 0.5458 | 0.5458 |
Echinococcus multilocularis | caspase | 0.0734 | 0.5458 | 0.5458 |
Brugia malayi | hypothetical protein | 0.0413 | 0.2326 | 0.2326 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.12 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Echinococcus multilocularis | cathepsin b | 0.0181 | 0.0067 | 0.0067 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0373 | 0.1935 | 0.1935 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.12 | 1 | 1 |
Mycobacterium ulcerans | proteasome PrcB | 0.12 | 1 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0785 | 0.5955 | 1 |
Leishmania major | metacaspase, putative | 0.0373 | 0.1935 | 0.1935 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0373 | 0.1935 | 0.1935 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0373 | 0.1935 | 0.1935 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.12 | 1 | 1 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.12 | 1 | 1 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0373 | 0.1935 | 0.1935 |
Echinococcus granulosus | proteasome prosome macropain | 0.12 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0181 | 0.0067 | 0.0067 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Effect (functional) | = 18.5 | Estrogenic activity in uterotrophic assay in immature mice at 2 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 25.5 | Estrogenic activity in uterotrophic assay in immature mice at 10.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 35.8 | Estrogenic activity in uterotrophic assay in immature mice at 50.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 39.5 | Estrogenic activity in uterotrophic assay in immature mice at 125 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 42.6 | Estrogenic activity in uterotrophic assay in immature mice at 250 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 45.7 | Estrogenic activity in uterotrophic assay in immature mice at 50.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 51 | Estrogenic activity in uterotrophic assay in immature mice at 10.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 52.3 | Estrogenic activity in uterotrophic assay in immature mice at 2 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 53.4 | Estrogenic activity in uterotrophic assay in immature mice at 250 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 18.5 | Estrogenic activity in uterotrophic assay in immature mice at 2 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 25.5 | Estrogenic activity in uterotrophic assay in immature mice at 10.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 35.8 | Estrogenic activity in uterotrophic assay in immature mice at 50.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 39.5 | Estrogenic activity in uterotrophic assay in immature mice at 125 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 42.6 | Estrogenic activity in uterotrophic assay in immature mice at 250 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 45.7 | Estrogenic activity in uterotrophic assay in immature mice at 50.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 51 | Estrogenic activity in uterotrophic assay in immature mice at 10.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 52.3 | Estrogenic activity in uterotrophic assay in immature mice at 2 ug subcutaneous dose | ChEMBL. | 2296015 |
Effect (functional) | = 53.4 | Estrogenic activity in uterotrophic assay in immature mice at 250 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 7.2 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 2 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 7.2 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 2 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 12.2 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 10.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 12.2 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 10.0 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 22 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice at 10.0 ug | ChEMBL. | 2296015 |
Inhibition (functional) | = 22 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice at 10.0 ug | ChEMBL. | 2296015 |
Inhibition (functional) | = 25.9 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 50.0 ug subcutaneous dose; p<0.01 | ChEMBL. | 2296015 |
Inhibition (functional) | = 25.9 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 50.0 ug subcutaneous dose; p<0.01 | ChEMBL. | 2296015 |
Inhibition (functional) | = 34.1 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 250 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 34.1 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 250 ug subcutaneous dose | ChEMBL. | 2296015 |
Inhibition (functional) | = 42 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 125 ug subcutaneous dose; p<0.01 | ChEMBL. | 2296015 |
Inhibition (functional) | = 42 % | Inhibition of 0.4 ug estrone-stimulated uterine growth in mice at 125 ug subcutaneous dose; p<0.01 | ChEMBL. | 2296015 |
Inhibition (functional) | < 67 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice at 100 ug | ChEMBL. | 2296015 |
Inhibition (functional) | = 67 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice supplemented with 0.3 mg of TP at 1000.0 ug | ChEMBL. | 2296015 |
Inhibition (functional) | < 67 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice at 100 ug | ChEMBL. | 2296015 |
Inhibition (functional) | = 67 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice supplemented with 0.3 mg of TP at 1000.0 ug | ChEMBL. | 2296015 |
Inhibition (functional) | < 77 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice at 1000 ug | ChEMBL. | 2296015 |
Inhibition (functional) | < 77 % | Inhibition of testosterone-stimulated seminal vesicle growth in castrated mice at 1000 ug | ChEMBL. | 2296015 |
RBA (binding) | = 0.23 | Relative binding affinity(RBA) for 50% displacement of [3H]-mibolerone from Androgen receptor compared to testorone | ChEMBL. | 2296015 |
RBA (binding) | = 17 | Relative binding affinity(RBA) for 50% displacement of [3H]-estradiol from Estrogen receptor compared to 17-beta-estradiol | ChEMBL. | 2296015 |
RBA (binding) | = 0.13 | Relative binding affinity(RBA) as ratio of progesterone and compound required to displace [3H]-org 2058 binding to Progesterone receptor by 50% | ChEMBL. | 2296015 |
RBA (binding) | = 0.23 | Relative binding affinity(RBA) for 50% displacement of [3H]-mibolerone from Androgen receptor compared to testorone | ChEMBL. | 2296015 |
RBA (binding) | = 17 | Relative binding affinity(RBA) for 50% displacement of [3H]-estradiol from Estrogen receptor compared to 17-beta-estradiol | ChEMBL. | 2296015 |
Relative seminal vesicle weight (functional) | = 38.3 | Relative effect on seminal vesicle weight in adult and castrated mice at 1000 ug dose | ChEMBL. | 2296015 |
Relative seminal vesicle weight (functional) | = 54.5 | Relative effect on seminal vesicle weight in adult and castrated mice at 100 ug dose | ChEMBL. | 2296015 |
Relative seminal vesicle weight (functional) | = 132 | Relative effect on seminal vesicle weight in adult and castrated mice at 10 ug dose | ChEMBL. | 2296015 |
Relative seminal vesicle weight (functional) | = 187.4 | Relative effect on seminal vesicle weight in adult and castrated mice supplemented with 0.3 mg TP at 1000 ug dose | ChEMBL. | 2296015 |
T/C (functional) | = 2 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 2 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Cytostatic effect on hormone-independent MDA-MB 231 human breast cancer cell proliferation at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Cytostatic effect on hormone-independent MDA-MB 231 human breast cancer cell proliferation at5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Effect on [3H]-thymidine incorporation into MDA-MB 231 human breast cancer cells at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Effect on [3H]-thymidine incorporation into MDA-MB 231 human breast cancer cells at 5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Cytostatic effect on hormone-independent MDA-MB 231 human breast cancer cell proliferation at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Cytostatic effect on hormone-independent MDA-MB 231 human breast cancer cell proliferation at5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Effect on [3H]-thymidine incorporation into MDA-MB 231 human breast cancer cells at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Effect on [3H]-thymidine incorporation into MDA-MB 231 human breast cancer cells at 5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 4 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 8 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 8 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-5 M | ChEMBL. | 2296015 |
T/C (functional) | = 10 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 10 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 5x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 25 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 25 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 45 % | Effect on [3H]-thymidine incorporation into MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 45 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 45 % | Effect on [3H]-thymidine incorporation into MDA-MB 231 human breast cancer cells at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 45 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 63 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 1x10E-7M | ChEMBL. | 2296015 |
T/C (functional) | = 63 % | Effect on [3H]-thymidine incorporation into MCF-7 human breast cancer cells at 1x10E-7M | ChEMBL. | 2296015 |
T/C (functional) | = 74 % | Cytostatic effect on hormone-independent MDA-MB 231 human breast cancer cell proliferation at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 74 % | Cytostatic effect on hormone-independent MDA-MB 231 human breast cancer cell proliferation at 1x10E-6M | ChEMBL. | 2296015 |
T/C (functional) | = 80 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-7M | ChEMBL. | 2296015 |
T/C (functional) | = 80 % | Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-7M | ChEMBL. | 2296015 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.